Der Wirkstoff in Liprolog, Insulin lispro, wird nach einer Methode hergestellt, die als „rekombinante DNA-Technologie“ bezeichnet wird.
The active substance in Liprolog, insulin lispro, is produced by a method known as ‘ recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin lispro.